Malaria Vaccines Market
The “Malaria Vaccines Market to 2024 – Global Analysis and Forecasts by Type and End-users” report provides a detailed overview of the major factors impacting the global market with the market share analysis and revenues of various sub segments

The Global Malaria Vaccines Market is pegged to be valued at US$ 8.5 million in 2018 and is projected to expand at a CAGR of 102.8% during the forecast period (2018-2024), as highlighted in a new report published by Coherent Market Insights. Rise in demand for vaccines for important indications on the backdrop of increasing focus on biological preparations is expected to be a major factor driving growth of the global malaria vaccines market over the foreseeable future.

According to World Health Organization (WHO) malaria fact sheet and World Bank estimates, over 40% of the global population is at risk of malaria. World Health Organization (WHO), there were around 214 million malaria cases reported in 2015, leading to 438,000 deaths worldwide. Over 70% of these deaths were among children under 5 years of age. Sub-Saharan Africa accounts for the highest share of global malaria burden, with around 89% of malaria cases and 91% of malarial deaths in 2015. Such high impact of this life-threatening disease is influencing governments across various countries, companies, investors, and non-profit organizations to contribute towards curbing spreading of this disease. Since the problem of malaria is burdening many of the emerging and under developed regions such as in Africa and Asia Pacific, various initiatives have been implemented in these regions to drive down high costs of the vaccine in development. For instance, in 2016, GSK announced plans to develop vaccines at a mere profit margin of 5% of the cost of the vaccine. Governments across most regions are actively involved in programs aimed at eliminating malaria. For instance, WHO had mobilized funding for pilot program in first phase between 2017 and 2020 by the global fund to fight against malaria and other disease such as AIDS and tuberculosis prevalent worldwide.

Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/37  

Some of the major players involved in global malaria vaccines market are GlaxoSmithKline plc, Sanaria Inc, Nobelpharma Co., Ltd., Sumaya Biotech and GenVec, Inc.

Scope of the Report

Global Malaria Vaccines Market, By Vaccines Type, 2018 – 2024 (US$ Million)

Introduction
Market Share Analysis, 2018 and 2024 (%)
Y-O-Y Growth Analysis, 2018 – 2024
Segment Trends
Pre-Erythrocytic Vaccine
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2018 – 2024, (US$ Million)
Erythrocytic Vaccine
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2018 – 2024, (US$ Million)
Multi-antigen Vaccine
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2018 – 2024, (US$ Million)

Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Vaccines Type
Market Snippet By Agent
Market Snippet By Distribution Channel
Market Snippet By Geography
Coherent Opportunity Map (COM)

Global Malaria Vaccines Market, By Agent, 2018 – 2024 (US$ Million)
Introduction
Market Share Analysis, 2018 and 2024 (%)
Y-O-Y Growth Analysis, 2018 – 2024
Segment Trends
Plasmodium Falciparum
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2018 – 2024, (US$ Million)
Plasmodium Vivax
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2018 – 2024, (US$ Million)

Get Discount: https://www.coherentmarketinsights.com/insight/request-discount/37 

Key takeaways of the malaria vaccines market:

The global malaria vaccines market is expected to expand at a CAGR of 102.8% during the forecast period (2016–2024) as there exists a large unrealized market especially in Africa, Asia Pacific, Latin America and Middle East
The Pre-Erythrocytic Vaccine dominates the market in the vaccines type segment, as it is used to prevent the infection completely, while blood-stage vaccines aim to reduce or eliminate the parasite load once a person is infected
Plasmodium Falciparum is the major agent segment of malaria vaccines market, as Plasmodium falciparum infection are induced by the asexual stages of the parasite that develop inside red blood cells, making it one of most severe forms of malaria among various types of parasites causing malaria

Table of Contents

Research Objective and assumption
Market Purview
Market Dynamics, Regulations, and Trends Analysis
Global Malaria Vaccines Market, By Vaccines Type, 2018 – 2024 (US$ Million)
Global Malaria Vaccines Market, By Agent, 2018 – 2024 (US$ Million)
Global Malaria Vaccines Market, By Distribution Channel, 2018 – 2024 (US$ Million)
Global Malaria Vaccines Market, By Geography, 2018 – 2024 (US$ Million)
Competitive Landscape
Section

Purchase Malaria Vaccines Market Report at https://www.coherentmarketinsights.com/insight/buy-now/37 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Shah
Email: Send Email
Phone: +1-206-701-6702
Address:1001 4th Ave, #3200
City: Seattle
State: Washington
Country: United States
Website: https://www.coherentmarketinsights.com/insight/request-customization/37

Leave a Reply

Your email address will not be published. Required fields are marked *